SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology & Drugs
An SI Board Since February 2001
Posts SubjectMarks Bans
232 7 0
Emcee:  2MAR$ Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
82BIOTECH STOCKS Disappointments hit biotech stocks By Ted Griffith, CBS.MarkeSusieQ1065-5/12/2002
81DUE DILIGENCE Can cancer drug heal Millennium? Biotech firm betting on experimSusieQ1065-5/5/2002
80MLNM ($23-$18) PE=0.. lower loss than expected ,rev's light Archive HeadlinSusieQ1065-5/5/2002
79AMGN ($56-$48)..PE=47...in-line, raises guidance... Archive Headline 25-Apr-02SusieQ1065-5/5/2002
78GILD ($28-$33) PE=79 Archive Headline 30-Apr-02 16:11 ET Gilead Sciences beatSusieQ1065-5/5/2002
77BGEN ($43-$41) PE=23...matches estimates, warns. Archive Headline 24-Apr-02 0SusieQ1065-5/5/2002
76CRA ($15-$14) PE=0.. beats and warns... Archive Headline 25-Apr-02 07:16 ET CSusieQ1065-5/5/2002
75AFFX ($27-$24) PE=0 Archive Headline 24-Apr-02 16:21 ET Affymetrix beats by tSusieQ1065-5/5/2002
74Cancer meeting may not boost biotech Presentations could be shrugged off in currSusieQ1065-5/5/2002
73GENZ ($43-$38) PE=0 Archive Headline 17-Apr-02 09:12 ET Genzyme hits low-end SusieQ1065-5/5/2002
72HGSI($17-$19-$15) PE=0... Archive Headline 15-Apr-02 08:16 ET Human Genome reSusieQ1065-5/5/2002
71IDPH ($64-$50) PE=80...18-Apr-02 16:15 ET IDEC Pharm matches estimates (IDPH) 6SusieQ1065-5/5/2002
70Teva ($44) Reports First Quarter 2002 Results Sales Up 11% EPS Up 60% to $0.64 2MAR$-4/30/2002
69Barrons April 25th, 2002 Biotech Stocks Are Still In La-La Land By EVELYN ELSusieQ1065-4/27/2002
68IMNX ( $30-$28.50) Profits Down Slightly Immunex Profits Down Slightly Because 2MAR$-4/23/2002
67<b><font color=fuchsia> ****NEW QTR ****2MAR$-4/23/2002
66GENZ ($44-40-42) P/E zero..misses by 2 cents, and revs light. Archive Headline SusieQ1065-4/17/2002
65MOGN ($14-$8) P/E zero..beats by 19 cents..announces halt of Phase 3 clinical trSusieQ1065-4/17/2002
64PacifiCare Health Systems Settles Claims Over Health-Care Premiums for Federal 2MAR$-4/12/2002
63Genentech DNA ($40-$43) Idec ($56-$62) lead biotechs higher Amgen's stock al2MAR$-4/11/2002
62AVANIR Pharmaceuticals Awarded $1 Million Research Grant To Develop a New DocosaTadsamillionaire-3/21/2002
6106:55 ET MYGN Myriad Genetics enters drug discovery pact with Abbott (36.05) SusieQ1065-3/12/2002
60PDLI Protein Design announces initiation of Phase II trial (16.48 -1.02) Comp2MAR$-3/12/2002
59PDLI ($17-$13) P/E Zero...in line with estimates, warns for FY02 Archive HeadliSusieQ1065-3/6/2002
58HGSI ($27-$19) P/E none of course....in-line with estimates, guides down quite aSusieQ1065-3/6/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News